Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 21 - Drugs for disorders of the muscular or neuromuscular system
Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287)
10/2003
10/02/2003WO2003080581A1 Phenanthridinones as parp inhibitors
10/02/2003WO2003080557A1 Substituted 4-aminocyclohexanols
10/02/2003WO2003080118A2 Combination of an aldosterone receptor antagonist and a fibric acid derivative
10/02/2003WO2003080105A2 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof
10/02/2003WO2003080104A2 Use of il-18 inhibitors for the treatment and/or prevention of peripheral vascular diseases
10/02/2003WO2003080053A1 Combination treatments for chemokine-mediated diseases
10/02/2003WO2003080046A1 Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane nmda, 5ht3, and neuronal nicotinic receptor antagoni sts
10/02/2003WO2003079969A2 Compositions and methods for treating and preventing necrosis
10/02/2003WO2003079750A2 ANTAGONISTIC ANTI-hFAS LIGAND HUMAN ANTIBODIES AND FRAGMENTS THEREOF
10/02/2003WO2002092759A3 Molecules for disease detection and treatment
10/02/2003WO2002055481A8 Prodrugs of excitatory amino acids
10/02/2003WO2002022573A3 Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies
10/02/2003US20030187199 Novel protein and gene
10/02/2003US20030187007 Inhibitors of protein kinase for the treatment of disease
10/02/2003US20030186989 Antihistamines; respiratory system disorders
10/02/2003US20030186981 Antiinflammatory agents; osteoporosis; rheumatic diseases; autoimmune diseases
10/02/2003US20030186974 Pyrrolyl- and imidazolyl-acid amide derivatives useful as inhibitors of PDE4 isozymes
10/02/2003US20030186960 Nervous system regeneration
10/02/2003US20030186945 Method of preparing and use of prodrugs of betulinic acid derivatives
10/02/2003US20030186894 Dry powder compositions having improved dispersivity
10/02/2003US20030186889 Diagnostic and medicament for analysing the cell surface proteome of tumour and inflammatory cells and for treating tumorous and inflammatory diseases, preferably using a specific chemokine receptor analysis and the chemokine receptor-ligand interaction
10/02/2003US20030186842 Contacting a cell population with an inhibiting effective amount of a reagent that suppresses the protease activity of at least one member of the interleukin-1beta- converting enzyme (ICE)/CED-3 family
10/02/2003US20030186337 Novel death associated proteins, and THAP1 and PAR4 pathways in apoptosis control
10/02/2003US20030186308 Prostacyclin-stimulating factor-2
10/02/2003US20030185824 Administering an inhibitor of the CD2/LFA-3 interaction, in combination with an auxiliary agent, such as UV-B
10/02/2003CA2480384A1 Phenanthridinones as parp inhibitors
10/02/2003CA2480302A1 Compositions and methods for treating and preventing necrosis
10/02/2003CA2479722A1 Combination of an aldosterone receptor antagonist and a fibric acid derivative
10/02/2003CA2478855A1 Use of il-18 inhibitors for the treatment and/or prevention of peripheral vascular diseases
10/02/2003CA2478839A1 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof
10/02/2003CA2474637A1 Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane nmda, 5ht3, and neuronal nicotinic receptor antagoni sts
10/01/2003EP1347990A2 Peptide mit inhibierender aktivität zur produktion von stickstoffmonoxid
10/01/2003EP1347974A1 Aminotriazolopyridiine derivatives as adenosine receptor ligands
10/01/2003EP1347972A1 Pyrazolo 3,4-c]pyridines as gsk-3 inhibitors
10/01/2003EP1347963A2 Benzofuran and benzothiophene derivatives as selective cox-2 inhibitors
10/01/2003EP1347746A1 Over-coated chewing gum formulations including tableted center
10/01/2003EP1206472B1 Oxazole and thiazole derivatives as neurotrophin production/secretion promoting agent
10/01/2003EP1019434B1 Inhibitors of metalloproteinases, their therapeutic use, and process for the production of the starting compound in their synthesis
10/01/2003CN1446227A Novel fibroblast growth factor (FRF23) and method for use
10/01/2003CN1446218A Benzimidazole derivatives, preparation method and therapeutic use thereof
10/01/2003CN1446193A Aminoadamantane derivatives as therapeutic agents
10/01/2003CN1446081A 神经毒素植入物 Neurotoxin implants
09/2003
09/30/2003US6627656 Method of treatment using phenyl and biaryl derivatives as prostaglandin E inhibitors and compounds useful therefore
09/30/2003US6627644 4-piperidinyl alkyl amine derivatives as muscarinic receptor antagonists
09/30/2003US6627637 I kappa B kinase inhibitors for treating various disorders including arthritis
09/30/2003US6627626 Antiinflammation agents and antiarthritic agents colon cancer, and Alzheimer's disease in mammals, preferably humans, dogs, cats and livestock animals.
09/30/2003US6627602 Preventing desensitization of receptors
09/25/2003WO2003078623A1 Functional molecule and process for producing the same
09/25/2003WO2003078435A1 Pyrazolo(1,5-a)pyridine derivatives as neurotransmitter modulators
09/25/2003WO2003078430A1 Amides of acetic and propionic acids
09/25/2003WO2003078425A1 Novel crystalline form of 5-[4-[[3-methyl-4-oxo-3,4-dihydroquinazolin-2-yl]methoxy]benzyl]thiazolidine-2,4-dione potassium salt
09/25/2003WO2003078415A1 Cyclic hemiacetal derivative and use thereof
09/25/2003WO2003078404A1 Pyrimidine derivatives
09/25/2003WO2003078395A1 Piperidine derivatives useful as modulators of chemokine receptor activity
09/25/2003WO2003077954A1 Method for determining effect of a clostridial toxin upon a muscle
09/25/2003WO2003077919A1 Fluorinated 4-azasteroid derivatives as androgen receptor modulators
09/25/2003WO2003068171A3 Method and composition for treatment of inflammation and aids-associated neurological disorders
09/25/2003WO2002064634A3 Human monoclonal antibodies to fc alpha receptor (cd89)
09/25/2003WO2002032842A3 Compounds with high monoamine transporter affinity
09/25/2003US20030181507 Use of 3-substituted oxindole derivatives as kcnq potassium channel modulators
09/25/2003US20030181497 Heterocyclic acridone inhibitors of IMPDH enzyme
09/25/2003US20030181481 Therapeutic drugs for treating central nervous system disorders
09/25/2003US20030181445 Administering compounds such as N-(3-(5-Cyano-1-(4-fluoro-phenyl)-1,3-dihydroisobenzofuran-1-yl)-1 -propyl)glycine ethyl ester, for prophylaxis of psychological disorders
09/25/2003US20030181379 Novel fibroblast growth factor (FGF23) and methods for use
09/25/2003US20030181362 Receptor
09/25/2003US20030181352 Substituted heterocyclic compounds
09/25/2003US20030180805 Methods and compositions for derepression of IAP-inhibited caspase
09/25/2003US20030180396 Central nervous system disorders; screening for allergens
09/25/2003US20030180395 Anxiolytic agents; analgesics; sleep disorders; antiinflammatory agents; central nervous system disorders
09/25/2003US20030180306 Controlling cell differentiation; muscular disorders
09/25/2003US20030180288 Methods and compositions for modulating immune response and for the treatment of inflammatory disease
09/25/2003US20030180287 Polypeptide formulation
09/25/2003US20030180269 Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
09/25/2003US20030178029 Method for determining effect of a clostridial toxin upon a muscle
09/25/2003CA2478762A1 Method for determining effect of a clostridial toxin upon a muscle
09/25/2003CA2478715A1 Novel pyrazolo [1,5-a]pyridine derivatives and their use as neurotransmitter modulators
09/24/2003EP1346033A2 Novel serine protease genes related to dppiv
09/24/2003EP1345941A1 Cyclin-dependent kinase (cdk) and glycolene synthase kinase-3 (gsk-3) inhibitors
09/24/2003EP1345929A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345928A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345927A1 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345926A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345925A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345922A1 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345627A1 Targeted modification of intracellular compounds
09/24/2003EP1345609A1 Tetrahydro-(benzo or thieno)-azepine-pyrazine and triazine derivatives as mglur 1 antagonists
09/24/2003EP1345567A2 Calcium channel transport polynucleotides, polypeptides, and antibodies
09/24/2003EP1345502A1 Creatine/citric acid compound, method for the production of the same and the use thereof
09/24/2003EP1196419B1 Potassium channel blocking agents
09/24/2003EP0944598B1 Substituted benzamide derivatives and pharmaceutical compositions containing them
09/24/2003CN1444600A Use of ADNF polypeptides for enhancing learning and memory
09/24/2003CN1444567A 咪唑衍生物 Imidazole derivatives
09/23/2003US6624186 Modulators of SKCa, IKCa and BKCa channels.
09/23/2003US6624163 P-acylaminomethyl-N-(4-methoxy-7-morpholin-4-yl-benzothiazol-2 -yl)-benzamides; treatment of diseases related to the adenosine receptor, such as Alzheimer's disease, depression, drug addiction, Parkinson's and Attention Deficit Hyperactivity Disorder
09/23/2003US6623730 Therapeutic uses of polymers and oligomers comprising gamma-hydroxybutyrate
09/23/2003CA2086654C Novel pharmaceutically active 1,2,4-triaminobenzene derivatives, processes for their preparation and pharmaceutical compositions containing them
09/18/2003WO2003076569A2 Novel polypeptides having sequence similarity to gdnfr and nucleic acids encoding the same
09/18/2003WO2003076565A2 Methods of using 46828, a human acyl-coa synthetase
09/18/2003WO2003076447A1 An optically acitve pyridine derivative and a medicament containing the same
09/18/2003WO2003076438A1 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
1 ... 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 ... 233